Discovery of a novel and potent, and urea isostere inhibitors series of dianilinopyrimidineurea of VEGFR2 tyrosine kinase

被引:33
|
作者
Sammond, DM [1 ]
Nallor, KE [1 ]
Veal, JM [1 ]
Nolte, RT [1 ]
Wang, LP [1 ]
Knick, VB [1 ]
Rudolph, SK [1 ]
Truesdale, AT [1 ]
Nartey, EN [1 ]
Stafford, JA [1 ]
Kumar, R [1 ]
Cheung, M [1 ]
机构
[1] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA
关键词
VEGFR2; FLK-1; KDR; kinase inhibitor;
D O I
10.1016/j.bmcl.2005.05.096
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of dianilinopyrimidineureas demonstrate potency as VEGFR2 kinase inhibitors. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3519 / 3523
页数:5
相关论文
共 50 条
  • [1] Discovery of highly potent and selective VEGFR2 kinase inhibitors for the treatment of rheumatoid arthritis
    Chen, Qingling
    Chen, Zhuoying
    Li, Feilong
    Zha, Haoyu
    He, Wei
    Jiang, Fei
    Wei, Jiamu
    Xu, Jiajia
    Li, Rong
    Cai, Li
    Liu, Xuesong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257
  • [2] Discovery of novel Benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors
    Hasegawa, Masaichi
    Nishigaki, Naohiko
    Washio, Yoshiaki
    Kano, Kazuya
    Harris, Philip A.
    Sato, Hideyuki
    Mori, Ichiro
    West, Rob I.
    Shibahara, Megumi
    Toyoda, Hiroko
    Wang, Liping
    Nolte, Robert T.
    Veal, James M.
    Cheung, Mui
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) : 4453 - 4470
  • [3] Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors
    Lv, Yongcong
    Li, Mengyuan
    Liu, Ting
    Tong, Linjiang
    Peng, Ting
    Wei, Lixin
    Ding, Jian
    Xie, Hua
    Duan, Wenhu
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 592 - 597
  • [4] Correlation of the in vitro and in vivo metabolic stability of a series of dianilinopyrimidine inhibitors of VEGFR2 tyrosine kinase
    Epperly, AH
    Stafford, JA
    Cook, ST
    Lin, J
    DRUG METABOLISM REVIEWS, 2002, 34 : 29 - 29
  • [5] Identification of potent and selective VEGFR receptor tyrosine kinase inhibitors having new amide isostere headgroups
    Gaudette, Frederic
    Raeppel, Stephane
    Nguyen, Hannah
    Beaulieu, Normand
    Beaulieu, Carole
    Dupont, Isabelle
    Macleod, A. Robert
    Besterman, Jeffrey M.
    Vaisburg, Arkadii
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 848 - 852
  • [6] Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases
    Claridge, Stephen
    Raeppel, Franck
    Granger, Marie-Claude
    Bernstein, Naomy
    Saavedra, Oscar
    Zhan, Lijie
    Llewellyn, David
    Wahhab, Amal
    Deziel, Robert
    Rahil, Jubrail
    Beaulieu, Normand
    Nguyen, Hannah
    Dupont, Isabelle
    Barsalou, Annie
    Beaulieu, Carole
    Chute, Ian
    Gravel, Serge
    Robert, Marie-France
    Lefebvre, Sylvain
    Dubay, Marja
    Pascal, Roussen
    Gillespie, Jeff
    Jin, Zhiyun
    Wang, James
    Besterman, Jeffrey M.
    MacLeod, A. Robert
    Vaisburg, Arkadii
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2793 - 2798
  • [7] A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis
    Bold, Guido
    Schnell, Christian
    Furet, Pascal
    McSheehy, Paul
    Brueggen, Josef
    Mestan, Juergen
    Manley, Paul W.
    Drueckes, Peter
    Burglin, Marion
    Duerler, Ursula
    Loretan, Jacqueline
    Reuter, Robert
    Wartmann, Markus
    Theuer, Andreas
    Bauer-Probst, Beatrice
    Martiny-Baron, Georg
    Allegrini, Peter
    Goepfert, Arnaud
    Wood, Jeanette
    Littlewood-Evans, Amanda
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (01) : 132 - 146
  • [8] Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors
    Harris, PA
    Cheung, M
    Hunter, RN
    Brown, ML
    Veal, JM
    Nolte, RT
    Wang, LP
    Liu, W
    Crosby, RM
    Johnson, JH
    Epperly, AH
    Kumar, R
    Luttrell, DK
    Stafford, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) : 1610 - 1619
  • [9] Discovery of New 4-Alkoxyquinazoline-Based Derivatives as Potent VEGFR2 Inhibitors
    Yin, Yong
    Sha, Shao
    Wang, Yan-Ting
    Wu, Xun
    Wang, She-Feng
    Qiao, Fang
    Lv, Peng-Cheng
    Zhu, Hai-Liang
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (05) : 1323 - 1329
  • [10] Discovery of a novel series of potent sphingosine kinase 1 and 2 dual inhibitors
    Li, Yihong
    Brown, Matthew
    Schmitt, Mike
    Wang, Sheldon
    Wanska, Maggie
    Connors, Richard
    Kayser, Frank
    Min, Xiaoshan
    Johnstone, Sheree
    Romanow, Bill
    Wang, Zhulun
    Cardozo, Mario
    Walker, Nigel
    Frank, Brendon
    Li, Shyun
    Wesche, Holger
    Shen, Shanling
    Wong, Mariwil
    Jeffries, Shawn
    Plant, Matthew
    Morgenstern, Kurt
    Xu, Guifen
    Carlson, Timothy
    Rex, Karen
    Gustin, Darin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243